The Patent Finder

Modulation of Hepatitis B Virus (HBV) Expression

Glaxo Group Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 61/478,040, filed Apr 21, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,642,752Modulation of Hepatitis B Virus (HBV) Expression
In force
 · High confidence
UsedRemaining
Glaxo Group LimitedIn forceHigh confidence
US 9,034,841Modulation of Hepatitis B Virus (HBV) Expression
In force
 · High confidence
Glaxo Group LimitedIn forceHigh confidence
US 9,127,278Modulation of Hepatitis B Virus (HBV) Expression
In force
 · High confidence
Glaxo Group LimitedIn forceHigh confidence
US 9,677,076Modulation of Hepatitis B Virus (HBV) Expression
In force
 · High confidence
Glaxo Group LimitedIn forceHigh confidence
Application 15/587,668Modulation of Hepatitis B Virus (HBV) Expression
Abandoned
Abandoned Aug 13, 2019
Glaxo Group LimitedAbandonedAbandoned Aug 13, 2019
Application 16/522,490Modulation of Hepatitis B Virus (HBV) Expression
Abandoned
Abandoned Sep 8, 2021
Glaxo Group LimitedAbandonedAbandoned Sep 8, 2021
Application 17/389,599Modulation of Hepatitis B Virus (HBV) Expression
Pending
Not granted
Glaxo Group LimitedPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Glaxo Group Limited.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited